X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5) 5
index medicus (5) 5
oncology (5) 5
melanoma (4) 4
cancer (3) 3
further section (3) 3
special section (3) 3
acute myelogenous leukemia (2) 2
analysis (2) 2
bone marrow (2) 2
chemotherapy (2) 2
combination (2) 2
disease-free survival (2) 2
drugs (2) 2
germany (2) 2
hematology, oncology and palliative medicine (2) 2
immunotherapy (2) 2
leukemia (2) 2
medicine (2) 2
mortality (2) 2
research article (2) 2
1st relapse (1) 1
3. interdisziplinäres expertenforum hautkrebs (1) 1
610 medizin (1) 1
accumulation (1) 1
adherence to renal dosing guidelines (1) 1
adult (1) 1
age factors (1) 1
aml (1) 1
animals (1) 1
anti-inflammatory agents (1) 1
anti-inflammatory agents, non-steroidal - pharmacology (1) 1
anti-inflammatory drugs (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antibodies (1) 1
antibody-dependent cell cytotoxicity - immunology (1) 1
antibody-dependent cell-mediated cytotoxicity (1) 1
anticancer properties (1) 1
antigens (1) 1
antigens, cd - immunology (1) 1
antigens, differentiation, myelomonocytic - immunology (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
artificial intelligence (1) 1
aspirin (1) 1
b16 melanoma (1) 1
basic cancer research (1) 1
biochemistry (1) 1
biological transport - drug effects (1) 1
biology (1) 1
biomarkers (1) 1
biomedicine (1) 1
bone-marrow (1) 1
c-myc (1) 1
c-myc protein (1) 1
cancer therapies (1) 1
cancer treatment (1) 1
cancer-patients (1) 1
carbonates (1) 1
carcinoma - genetics (1) 1
carcinoma - metabolism (1) 1
cd123 (1) 1
cd123 antigen (1) 1
cd16 antigen (1) 1
cd33 (1) 1
cd8 (1) 1
cd8 t cells (1) 1
cd8+ t cells (1) 1
cell growth (1) 1
cell line, tumor (1) 1
cell proliferation (1) 1
cell proliferation - drug effects (1) 1
chemical and pharmacologic phenomena (1) 1
chemotherapy and drug treatment (1) 1
chemotherapy, adjuvant (1) 1
cisplatin (1) 1
classification (1) 1
clinical trials (1) 1
colon-cancer cells (1) 1
continental margins (1) 1
cratons (1) 1
creatinine (1) 1
cyclooxygenase-2 (1) 1
cytarabine (1) 1
cytarabine - therapeutic use (1) 1
dacarbazine - therapeutic use (1) 1
data analysis (1) 1
data processing (1) 1
daunorubicin - therapeutic use (1) 1
ddc:610 (1) 1
dendritic cells (1) 1
dermatology - standards (1) 1
dextrose (1) 1
diclofenac (1) 1
diclofenac - pharmacology (1) 1
disease (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Quaternary International, ISSN 1040-6182, 12/2013, Volume 318, pp. 128 - 138
In this work, the first results of ice rafted detritus (IRD) provenance related to Heinrich Events in the NW Iberian Margin are presented and discussed. This... 
LATE QUATERNARY SEDIMENTATION | NORTH-ATLANTIC OCEAN | GEOGRAPHY, PHYSICAL | GEOSCIENCES, MULTIDISCIPLINARY | EVENTS | TEMPERATURE | ICEBERG DISCHARGES | STABLE-ISOTOPE | PROVENANCE | HEINRICH LAYERS | ICE-RAFTED DEBRIS | SEA | Continental margins | Carbonates | Cratons | Terrigenous sediments
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e66987
..., Katrin Singer 1, Anton Seilbeck 1, Andreas Mackensen 6, Oliver Grauer 7,8, Peter Hau 8,9, Katja Dettmer 5, Reinhard Andreesen 1,2, Peter J. Oefner 5, Marina Kreutz... 
MONOCARBOXYLATE TRANSPORTERS | COLON-CANCER CELLS | SALICYLIC-ACID | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | INDUCED APOPTOSIS | MULTIDISCIPLINARY SCIENCES | IN-VIVO | GROWTH | C-MYC | MALIGNANT-MELANOMA | INDUCE APOPTOSIS | Melanoma - metabolism | Neoplasms - metabolism | Diclofenac - pharmacology | Humans | Lactic Acid - metabolism | Leukemia - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Gene Expression Regulation - drug effects | Animals | Neoplasms - genetics | Melanoma - genetics | Intracellular Space - metabolism | Cell Line, Tumor | Glucose - metabolism | Carcinoma - genetics | Biological Transport - drug effects | Cell Proliferation - drug effects | Proto-Oncogene Proteins c-myc - genetics | Carcinoma - metabolism | Metabolic Networks and Pathways - drug effects | Leukemia - genetics | Glucose metabolism | Aspirin | Anti-inflammatory drugs | Leukemia | Genes | Melanoma | Glucose | Gene expression | Dextrose | Cell proliferation | Drugs | c-Myc protein | Myc protein | Kinases | Cancer therapies | Accumulation | Diclofenac | Anticancer properties | Cell growth | Hydroxycinnamic acid | Psychiatrists | Nonsteroidal anti-inflammatory drugs | Glucose transporter | Efflux | Secretion | Tumor cells | Lactate dehydrogenase | Inflammation | Metabolism | Anti-inflammatory agents | L-Lactate dehydrogenase | Inhibitors | Glycolysis | Lactic acid | Cyclooxygenase-2 | Intracellular | Transporter
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2010, Volume 150, Issue 5, pp. 574 - 586
Journal Article
OncoImmunology, ISSN 2162-4011, 06/2016, Volume 5, Issue 6, p. e1101206
Classical tumor therapy consists of surgery, radio(RT)- and/or chemotherapy. Additive immunotherapy has gained in impact and antitumor in situ immunization... 
hyperthermia | NK cells | in situ immunization | CD8 | immunogenic cell death | radiotherapy | melanoma | T cells | NATURAL-KILLER-CELLS | DENDRITIC CELLS | IFN-GAMMA | MOUSE | TUMOR-CELLS | RELEASE | IMMUNOLOGY | GAMMA PRODUCTION | B16 MELANOMA | ONCOLOGY | IMMUNE-RESPONSES | CD8(+) T cells
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 08/2013, Volume 36, Issue 5, pp. 28 - 28
..., Palliativmedizin Zentrum für Innere Medizin Universitätsmedizin Rostock Ernst-Heydemann-Straße 6 18055 Rostock, Deutschland Prof. Dr. med. Andreas Hochhaus Abt. Hämatologie... 
Further Section
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 04/2011, Volume 34, Issue 2, pp. I - V
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 04/2006, Volume 4, Issue 4, pp. 344 - 349
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 04/2012, Volume 35, Issue 2, pp. I - IV
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 10/2014, Volume 37, Issue 4, pp. 1 - 1
...Oncol Res Treat 2014;37(suppl 4):1 Published online: September 30, 2014 DOI: 10.1159/000366429 V orwort Axel Hauschild a Oliver Kölbl b Andreas Mackensen c... 
Further Section
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 05/2015, Volume 38, Issue 3, pp. 1 - 1
...Oncol Res Treat 2015;38(suppl 3):1 DOI: 10.1159/000381404 V orwort Axel Hauschild a Oliver Kölbl b Andreas Mackensen c Dirk Schadendorf d a Klinik für... 
Further Section
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 06/2013, Volume 36, Issue 4, pp. 1 - 1
...Onkologie 2013;36(suppl 4):1 Published online: 7. Mai 2013 DOI: 10.1159/000350919 Vorwort Axel Hauschild a Oliver Kölbl b Andreas Mackensen c Dirk Schadendorf... 
3. Interdisziplinäres Expertenforum Hautkrebs
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 04/2012, Volume 35, Issue 2, pp. 1 - 1
...Onkologie 2012;35(suppl 2):1 Published online: 23. April 2012 DOI: 10.1159/000337701 Vorwort Axel Hauschild a Oliver Kölbl b Andreas Mackensen c Dirk... 
Special Section
Journal Article
Medizinische Klinik, ISSN 0723-5003, 4/2010, Volume 105, Issue 4, pp. 232 - 236
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.